Back to Journals

Open Access Journal of Clinical Trials

Professor Frankel

Chief of medical oncology, USA Mitchell Cancer Institute, Alabama, USA, United States

Professor Frankel

Editor-in-Chief:  Professor Arthur E. Frankel

Dr. Arthur Frankel is the chief of medical oncology at USA Mitchell Cancer Institute, Alabama, USA.

Dr. Frankel earned his MD from Harvard Medical School and conducted his medicine internship at Yale University. Soon after completing his degree, Dr. Frankel began as a research scientist with the National Institute of Health and later completed his medicine residency and oncology fellowship at Stanford University. He is board certified in internal medicine, medical oncology and hematology. Dr. Frankel is a member of the American Society of Clinical Oncology, American Society of Hematology and American Association of Cancer Research.

Dr. Frankel's main focus is combining the clinical practice of hematology/oncology with an investigative cancer drug development program to better move targeted cancer therapeutics into the clinical setting. He has participated in the development of targeted peptide toxins also called immunotoxins for melanoma, breast cancer, ovarian cancer, leukemia, lymphoma, chronic pain, prostate cancer, and thyroid cancer. He has performed phase I clinical trials for many of these agents. He has over 190 peer-reviewed articles, has edited three books, organized for international symposia and received grants from the American Cancer Society, the Leukemia and Lymphoma Society, NIH and the Van Andel Foundation.

Editorial Board

Abdelhamid Attia, Professor, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Cairo, Cairo, Egypt

Adam M. Brufsky, Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, USA

Rudolph J. Castellani, Professor of Pathology, Director, Center for Neuropathology, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA

Mario Cazzola, Honorary Professor of Respiratory Medicine, Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy

William Checkley, Associate Professor of Medicine, International Health, and Biostatistics; Director, Fogarty Global Health Fellowship at Johns Hopkins University; Director, Center for Global Non-Communicable Diseases, Division of Pulmonary and Critical Care Johns Hopkins University, Baltimore, Maryland, USA

E. David Crawford, Professor, University of Colorado Cancer Center, University of Colorado Health Sciences Center, Denver, CO, USA

Tarek El-Bialy, PhD, FRCD(C), EMBA, ABO Alexander von Humboldt Experienced Research Fellow, Senator, University of Alberta Senate RCDC, Councilor for Orthodontics, Professor of Orthodontics and Biomedical Engineering, Faculty of Medicine and Dentistry, 7-020D Katz Group Centre for Pharmacy and Health Research, University of Alberta, Edmonton, Alberta, Canada

Stephen E. Gitelman, MD, Mary B. Olney, MD / KAK Distinguished Professorship in Pediatric Diabetes and Clinical Research; Professor of Pediatrics; Chief, Division of Pediatric Endocrinology and Diabetes, University of California at San Francisco, San Francisco, CA, USA

Robert Hauser, Professor, Department of Neurology, University of South Florida College of Medicine, FL, USA

Mallory O. Johnson, Department of Medicine, University of California, San Francisco, CA, USA

Roger S. McIntyre, M.D., FRCPC, Professor of Psychiatry and Pharmacology, University of Toronto; Head, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada

Ian S. Zagon, Professor, Department of Neural and Behavioural Sciences, Pennsylvania State University Milton S. Hershey Medical Center, Hershey, PA, USA